Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients – A systematic review
Author:
Funder
Netherlands organisation for health research and development
Dutch cancer society
Dutch health care insurance company Zilveren kruis Achmea
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference70 articles.
1. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap;Barber;Stat. Med.,2000
2. Treatment of advanced non small cell lung cancer;Bareschino;J. Thorac. Dis.,2011
3. Review of the reporting of survival analyses within randomised controlled trials and the implications for meta-analysis;Batson;PLoS One,2016
4. Median survival or mean survival: which measure is the most appropriate for patients, physicians, and policymakers?;Ben-Aharon;Oncologist,2019
5. Milestone analyses of immune checkpoint inhibitors, targeted therapy, and conventional therapy in metastatic non-small cell lung cancer trials: a meta-analysis;Blumenthal;JAMA Oncol.,2017
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test;Cancer Investigation;2024-05-21
2. Academia and society should join forces to make anti‐cancer treatments more affordable;Molecular Oncology;2024-04-18
3. Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panel;2023-12-21
4. Analytical and clinical validation of a targeted-enhanced whole genome sequencing-based comprehensive genomic profiling test;2023-12-18
5. Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands;Scientific Reports;2023-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3